STOCK TITAN

DECISION DIAGNOSTICS CORP - $DECN STOCK NEWS

Welcome to our dedicated page for DECISION DIAGNOSTICS news (Ticker: $DECN), a resource for investors and traders seeking the latest updates and insights on DECISION DIAGNOSTICS stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DECISION DIAGNOSTICS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DECISION DIAGNOSTICS's position in the market.

-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.83%
Tags
covid-19
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.94%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
covid-19
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
covid-19
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.78%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.95%
Tags
covid-19
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.76%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.49%
Tags
covid-19
DECISION DIAGNOSTICS CORP

OTC:DECN

DECN Rankings

DECN Stock Data

357
Custom Computer Programming Services
Professional, Scientific, and Technical Services
Link
United States of America
Westlake Village

About DECN

decision diagnostics corp. develops smart phone based electronic medical record (emr) technologies. the company offers prescription and non-prescription diagnostics; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services. it manufactures and distributes genultimate! glucose test strips, a class ii medical device for at-home use for the measurement of glucose; petsure! glucose test strip for the glucose testing of dogs and cats designed to work with the zoetis alphatrak and alphatrak ii glucometers, a legacy meter; genultimate! 4pets glucose system, a proprietary glucose measuring system, including genultimate! 4pets test strip and avantage meter, for the testing of dogs, cats, and horses; and genultimate! sure and genultimate! precis test strips. in addition, it engages in the acquisition and holding of intellectual property including patents and trademark